CXApp Inc. Files S-1/A Amendment

TL;DR

CXApp Inc. updated its S-1/A filing on Oct 2, 2024. Formerly KINS Tech, now Palo Alto based. Financials for 2022-2024 Q2 detailed.

AI Summary

CXApp Inc. filed an S-1/A amendment on October 2, 2024, detailing its financial information. The company, formerly KINS Technology Group, Inc. until August 12, 2020, is based in Palo Alto, CA. The filing covers the period from January 1, 2024, to June 30, 2024, and includes financial data for its predecessor and successor entities for the years ending December 31, 2022, and 2023.

Why It Matters

This S-1/A filing provides updated information for investors and the public regarding CXApp Inc.'s financial status and corporate structure, crucial for understanding its current market position.

Risk Assessment

Risk Level: medium — S-1/A filings often indicate a company is preparing for significant corporate actions like an IPO or major debt offering, which inherently carry market risks.

Key Numbers

• 2024 Q2 — Reporting Period (Covers financial data for the second quarter of 2024.)
• 2022-2023 — Fiscal Years (Includes financial data for these prior fiscal years.)

Key Players & Entities

• CXApp Inc. (company) — Filer
• KINS Technology Group, Inc. (company) — Former company name
• 20241002 (date) — Filing date
• Palo Alto, CA (location) — Company address
• 20200812 (date) — Date of name change

FAQ

Key Financial Figures

• $0.0001 — 0,000 shares of common stock, par value $0.0001 per share (the "common stock") being ne
• $0.004 — tyholders") at a price of approximately $0.004 per share, (ii) the resale of up to 10,
• $11.50 — se common stock at an exercise price of $11.50 per share, which were originally issued
• $1.00 — w) in a private placement at a price of $1.00 per private placement warrant, (iii) 24
• $9.94 — Advisory Agreement was entered into was $9.94. Therefore, the implied value of BTIG's
• $994,000 — the Advisory Agreement is approximately $994,000. The Advisory Agreement was entered int
• $4.10 — price of the Company's common stock was $4.10. We are also registering the resale o
• $10 million — the aggregate purchase amount of up to $10 million. Upon the terms and subject to the cond
• $1.59 — common stock as reported by Nasdaq was $1.59 per share and the closing price of our
• $0.24 — d the closing price of our warrants was $0.24 per warrant. Investing in shares of ou

Filing Documents

• cxappinc_s1a2.htm (S-1/A) — 3637KB
• cxappinc_ex5-1.htm (EX-5.1) — 42KB
• cxappinc_ex23-1.htm (EX-23.1) — 3KB
• cxappinc_ex23-2.htm (EX-23.2) — 2KB
• 0001829126-24-006612.txt ( ) — 14139KB
• cxai-20240630.xsd (EX-101.SCH) — 82KB
• cxai-20240630_cal.xml (EX-101.CAL) — 127KB
• cxai-20240630_def.xml (EX-101.DEF) — 517KB
• cxai-20240630_lab.xml (EX-101.LAB) — 477KB
• cxai-20240630_pre.xml (EX-101.PRE) — 567KB
• cxappinc_s1a2_htm.xml (XML) — 2494KB

USE OF PROCEEDS

USE OF PROCEEDS 39 DETERMINATION OF OFFERING PRICE 40 DIVIDEND POLICY 41 MARKET INFORMATION 42 Unaudited Pro Forma Condensed Combined Financial Information 43 NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION 47

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 50 RESULTS OF OPERATIONS 56

BUSINESS

BUSINESS 79 Management 89 Executive and Director Compensation 97 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 100 PRINCIPAL STOCKHOLDERS 105 Selling Securityholders 106

Description of Capital Stock

Description of Capital Stock 109 SECURITIES ACT RESTRICTIONS ON RESALE OF COMMON STOCK 114 PLAN OF DISTRIBUTION (CONFLICT OF INTEREST) 115 LEGAL MATTERS 118 EXPERTS 118 Where You Can Find More Information 118 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM F-2 i ABOUT THIS PROSPECTUS You should rely only on the information contained in this prospectus or in any applicable prospectus supplement prepared by us or on our behalf. Neither we nor the Selling Securityholders have authorized anyone to provide any information or to make any representations other than those contained in this prospectus, any accompanying prospectus supplement or any free writing prospectus we have prepared. We and the Selling Securityholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the securities offered hereby and only under circumstances and in jurisdictions where it is lawful to do so. No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. This prospectus is not an offer to sell securities, and it is not soliciting an offer to buy securities, in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus or any prospectus supplement is accurate only as of the date on the front of those documents only, regardless of the time of delivery of this prospectus or any applicable prospectus supplement, or any sale of a security. Our business, financial condition, results of operations and prospects may have changed since those dates. This prospectus is part of a registration statement on Form S-1 that we filed with the SEC using the "shelf" registration proce

View Full Filing

View this S-1/A filing on SEC EDGAR